Vimarsana
Biggest News Aggregation in the World

Page 3 - Derek Chalmers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Derek Chalmers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Derek Chalmers Today - Breaking & Trending Today

13 Best Hemp Stocks to Buy Now - Insider Monkey - Vimarsana News

13 Best Hemp Stocks to Buy Now - Insider Monkey

13 Best Hemp Stocks to Buy Now Weedmaps define Hemp as “A dioecious plant, which means it can be separated into male and female plants. These plants have served a wide variety of purposes for more than 10,000 years: for fiber (from the plant’s stems), protein (from seeds), and oils and smokable portions (from the leaves and flowers). Hemp fibers can be used to make items including paper, clothing, furnishing fabric, rope, and building materials.”. Some people may confuse hemp with marijuana. Although both contain tetrahydrocannabinol (THC) and are classified as cannabis, the variety cul...

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus - Vimarsana News

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus

TMCnet News Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus [December 28, 2020] Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for KORSUVA™ Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus First NDA submission for Company’s lead program, KORSUVA™ Injection – NDA submission includes request for Priority Review under Breakthrough Therapy Designation for KORSUVA Injection – STAMFORD, Conn., Dec. 28, 20...

Source: tmcnet.com
Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients - Vimarsana News

Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients

Stamford-based Cara Therapeutics seeks FDA approval for drug for kidney-disease patients FacebookTwitterEmailLinkedInRedditPinterest Photo: Michael Cummo / Hearst Connecticut Media STAMFORD — Biotech firm Cara Therapeutics has submitted its first new drug application to the federal Food & Drug Administration for an injectable treatment for the itch condition pruritus, the Stamford-based company announced Monday. Korsuva would treat moderate to severe pruritus in patients with chronic kidney disease who are undergoing hemodialysis. Stamford-based Cara has requested a “priority” review fo...